Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 13 Nov 2023

Tianlong Science and Technology (Shaanxi, China) is showcasing its cutting-edge products and innovative molecular diagnostic solutions at MEDICA 2023. The company is also highlighting its classic integrated PCR lab solution and its brand new product - Panall 8000 All-in-One Molecular Diagnosis System at the show. The revolutionary Panall 8000 All-in-One Molecular Diagnosis System seamlessly integrates various diagnostic stages, setting new standards for efficiency and accuracy in the field of molecular diagnostics.

Tianlong is also exhibiting the RBT320 Agglutination Automated Detection System which is intended for the detection of Brucellosis based on the Rose Bengal Test (RBT) method. Designed for automating laboratory workflow, Tianlong RBT320 integrates various functions, including automatic sample loading, sample mixing, photographing, AI image recognition, and result interpretation. With optimized efficiency, RBT320 can process 320 samples per hour and is suitable for large-scale screening of Brucella antibodies. Tianlong RBT320 is highly automated and can empower labs with maximum efficiency and effectively avoid human errors, while the use of the RBT method can also be cost-effective for labs.

At MEDICA 2023, Tianlong is also presenting the iGeneCase 1600 Diagnostics-in-a-Suitcase, and PANA 9600X Automated Nucleic Acid Workstation, as well as a variety of products and compatible reagents. For instance, Tianlong's solution for nucleic acid detection of influenza virus is designed to identify and differentiate various strains, including Influenza A/B, Influenza C, Influenza A(H1&H3), Influenza A(H1N1), Influenza A(H3N2), and Influenza A(H5N1), as well as multiplex kit for Influenza A/B/Human Adenovirus/2019-nCoV. This comprehensive solution provides a scientific basis for accurate diagnosis and treatment of individuals with symptoms of influenza.

Related Links:
Tianlong Science and Technology

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.